Eligibility for differentiated models of HIV treatment service delivery: an estimate from Malawi and Zambia.
Journal
AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219
Informations de publication
Date de publication:
01 03 2020
01 03 2020
Historique:
pubmed:
26
11
2019
medline:
9
2
2021
entrez:
26
11
2019
Statut:
ppublish
Résumé
Little is known about the proportion of HIV-positive clients on antiretroviral therapy (ART) who meet stability criteria for differentiated service delivery (DSD) models. We report the proportion of ART clients meeting stability criteria as part of screening for a randomized trial of multimonth dispensing in Malawi and Zambia. For a DSD trial now underway, we screened HIV-positive clients aged at least 18 years presenting for HIV treatment in 30 adult ART clinics in Malawi and Zambia to determine eligibility for DSD. Stability was defined as on first-line ART (efavirenz/tenofovir/lamivudine) for at least 6 months, no ART side effects, no toxicity or infectious complications, no noncommunicable diseases being treated in ART clinic, no lapses in ART adherence in the prior 6 months (>30 days without taking ART), and if female, not pregnant or breastfeeding. In total, 3465 adult ART clients were approached between 10 May 2017 and 30 April 2018 (Malawi: 1680; Zambia: 1785). Of the 2938 who answered screening questions (Malawi: 1527; Zambia: 1411), 2173 (73.5%) met criteria for DSD eligibility (Malawi: 72.8%; Zambia: 74.3%). The most common reasons for ineligibility were being on ART less than 6 months (9.6%) and a regimen other than standard first-line (7.9%). Approximately three-quarters of all adult clients presenting at ART clinics in Malawi and Zambia were eligible for DSD using a typical definition of stability. High uptake of DSD models by eligible clients would have a major impact on the infrastructure and the allocation of HIV treatment resources.
Sections du résumé
BACKGROUND
Little is known about the proportion of HIV-positive clients on antiretroviral therapy (ART) who meet stability criteria for differentiated service delivery (DSD) models. We report the proportion of ART clients meeting stability criteria as part of screening for a randomized trial of multimonth dispensing in Malawi and Zambia.
METHODS
For a DSD trial now underway, we screened HIV-positive clients aged at least 18 years presenting for HIV treatment in 30 adult ART clinics in Malawi and Zambia to determine eligibility for DSD. Stability was defined as on first-line ART (efavirenz/tenofovir/lamivudine) for at least 6 months, no ART side effects, no toxicity or infectious complications, no noncommunicable diseases being treated in ART clinic, no lapses in ART adherence in the prior 6 months (>30 days without taking ART), and if female, not pregnant or breastfeeding.
RESULTS
In total, 3465 adult ART clients were approached between 10 May 2017 and 30 April 2018 (Malawi: 1680; Zambia: 1785). Of the 2938 who answered screening questions (Malawi: 1527; Zambia: 1411), 2173 (73.5%) met criteria for DSD eligibility (Malawi: 72.8%; Zambia: 74.3%). The most common reasons for ineligibility were being on ART less than 6 months (9.6%) and a regimen other than standard first-line (7.9%).
CONCLUSION
Approximately three-quarters of all adult clients presenting at ART clinics in Malawi and Zambia were eligible for DSD using a typical definition of stability. High uptake of DSD models by eligible clients would have a major impact on the infrastructure and the allocation of HIV treatment resources.
Identifiants
pubmed: 31764076
doi: 10.1097/QAD.0000000000002435
pii: 00002030-202003010-00015
doi:
Substances chimiques
Anti-HIV Agents
0
Lamivudine
2T8Q726O95
Tenofovir
99YXE507IL
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
475-479Subventions
Organisme : NIAID NIH HHS
ID : L30 AI075486
Pays : United States
Organisme : PEPFAR
Pays : United States
Références
Grimsrud A, Barnabas RV, Ehrenkranz P, Ford N. Evidence for scale up: the differentiated care research agenda. J Int AIDS Soc 2017; 20: (Suppl 4): 22024.
Decroo T, Telfer B, Dores CD, White RA, Santos ND, Mkwamba A, et al. Effect of Community ART Groups on retention-in-care among patients on ART in Tete Province, Mozambique: a cohort study. BMJ Open 2017; 7:e016800.
Nakiwogga-Muwanga A, Katabira E, Sempa J, Kambugu A, Nakibuuka-Lubwama E, Lamorde M, et al. A pharmacy-only refill program at a large HIV clinic in Uganda: experience and satisfaction of patients. J Int Assoc Provid AIDS Care 2014; 13:264–268.
Prust ML, Banda CK, Nyirenda R, Chimbwandira F, Kalua T, Jahn A, et al. Multimonth prescriptions, fast-track refills, and community ART groups: results from a process evaluation in Malawi on using differentiated models of care to achieve national HIV treatment goals. J Int AIDS Soc 2017; 20: (Suppl 4): 21650.
Mody A, Roy M, Sikombe K, Savory T, Holmes C, Bolton-Moore C, et al. Improved retention with 6-month clinic return intervals for stable human immunodeficiency virus-infected patients in Zambia. Clin Infect Dis 2018; 66:237–243.
Tsondai PR, Wilkinson LS, Grimsrud A, Mdlalo PT, Ullauri A, Boulle A. High rates of retention and viral suppression in the scale-up of antiretroviral therapy adherence clubs in Cape Town, South Africa. J Int AIDS Soc 2017; 20: (Suppl 4): 21649.
Hoffman R, Bardon A, Rosen S, Fox M, Kalua T, Xulu T, et al. Varying intervals of antiretroviral medication dispensing to improve outcomes for HIV patients (The INTERVAL Study): study protocol for a randomized controlled trial. Trials 2017; 18:476.
Malawi Ministry of Health. Malawi Guidelines for Clinical Management of HIV in Children and Adults, 3rd edn; 2016. https://www.hiv.health.gov.mw/.
Zambia Ministry of Health. Zambia Consolidated Guidelines for HIV Treatment and Prevention; 2016. https://aidsfree.usaid.gov/sites/default/files/zambia_hiv_gl2016.pdf.
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2016; Geneva: World Health Organization, Available at http://www.who.int/hiv/pub/arv/arv-2016/en/. [Accessed 12 February 2019].
Nhassengo P, Cataldo F, Magaco A, Hoffman RM, Nerua L, Saide M, et al. Barriers and facilitators to the uptake of Test and Treat in Mozambique: a qualitative study on patient and provider perceptions. PLoS One 2018; 13:e0205919.
Ayieko J, Brown L, Anthierens S, Van Rie A, Getahun M, Charlebois ED, et al. ‘Hurdles on the path to 90-90-90 and beyond’: qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat. PLoS One 2018; 13:e0202990.
Roy M, Mukumbwa-Mwenechanya M, Efronson E, Mwansa L, Sharma A, Sikazwe I, et al. Uptake and adaptation of community adherence groups in Zambia. Poster Presentation at the Conference on Retroviruses and Opportunistic Infections, Seattle, Washington. 13–16 February 2017.
Eshun-Wilson I, Mukumbwa-Mwenechanya M, Kim HY, Zanolini AL, Mwamba C, Dowdy D, et al. Differentiated care preferences of stable patients on ART in Zambia. Poster Presentation (Abstract 1054) at the Conference on Retroviruses and Opportunistic Infections. 4–7 March 2019.